Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.0029.03%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.20M | 3.19M | 1.91M | -7.02M | -8.32M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 384.80K | -8.63M | -7.98M | 2.02M | 3.79M |
| Change in Net Operating Assets | -898.60K | -417.10K | -663.60K | 169.10K | 57.20K |
| Cash from Operations | -3.72M | -5.86M | -6.73M | -4.84M | -4.47M |
| Capital Expenditure | -- | -- | -- | 19.10K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -24.60K | -24.60K |
| Cash from Investing | -- | -- | -- | -5.40K | -24.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 8.71M | 8.71M | 8.71M |
| Repurchase of Common Stock | -- | -204.00K | -204.00K | -204.00K | -204.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -117.30K | -341.50K | -341.50K | -1.49M | -3.76M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -385.50K |
| Cash from Financing | -117.30K | -545.50K | 8.16M | 7.02M | 4.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.83M | -6.40M | 1.43M | 2.18M | -138.50K |